Another study showed that pterostilbene (PS) treatment was associated with a reduction in oxidative markers NOS, COX-2, AR, and NF-κB and an increase in antioxidant glutathione reductase in an azoxymethane (AOM)-induced colon cancer model. This evidence concerns the gene NFKB1 and colonic neoplasm.